Jan. 5, 2007 — A French court has ruled that Abbott Laboratories’ Xience V drug-eluting coronary stents infringe patents ...
Jan. 5, 2007 — An announcement from AstraZeneca is expected soon about the company’s experimental heart drug AGI-1067, the company’s partner AtheroGenics Inc. hopes to present results from a pivotal Phase III clinical trial to the American College of Cardiology (ACC) meeting in New Orleans.
Non-white, low-income patients without commercial insurance are more likely to delay diagnosis of peripheral vascular ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
AP reports that a Dec. 27 Medicare proposal may could double the number of hospitals authorized to implant the HeartMate ...
HMS Technologies, Inc. (HMS), the exclusive federal distributor for the commercial versions of the EZ-IO Emergency ...
Heartwire cites results of a new study finding that current heart-failure performance measures, with the exception of ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Dual-chamber pacing coupled with Boston Scientific's AV Search Hysteresis (AVSH) programming has the potential to reduce ...
A review by physicians at Tulane University School of Public Health and Tropical Medicine shows that Vitamin B12 ...
Swiss researchers may have discovered the reason drug-eluting stents cause thrombosis, and their study results are ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Reuters reports that a study of military veterans suffering from post-traumatic stress disorder showed that more severe their anxiety, the greater their risk of heart disease. Adding to the long-recognized connection between stress and heart disease, researchers at the Harvard School of Public Health in Boston said that relationship existed among nearly 2,000 Boston-area veterans.
A new intravascular MRI catheter developed by Topspin Medical has received CE Mark approval, and the Israeli company ...
Implant Sciences Corp. a wholly-owned German subsidiary of CorNova, Inc., has received CE Mark marketing approval for ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The FDA has granted 510(k) marketing clearance for Atrium Medical Corp.’s ClearWay RX, a therapeutic perfusion catheter ...
The latest in thrombus removal devices from Possis has received FDA clearance — the new AngioJet Ultra Thrombectomy System is the next-generation, re-engineered version of the company’s AngioJet Rheolytic Thrombectomy System.
The first patients to receive a new, implanted heart-monitoring device underwent procedures recently at the Clinica ...
January 04, 2007
